[HTML][HTML] Challenges and controversies in human mesenchymal stem cell therapy

B Lukomska, L Stanaszek, E Zuba-Surma… - Stem cells …, 2019 - hindawi.com
Stem cell therapy is being intensely investigated within the last years. Expectations are high
regarding mesenchymal stem cell (MSC) treatment in translational medicine. However …

Stem cell therapy in heart diseases–cell types, mechanisms and improvement strategies

P Müller, H Lemcke, R David - Cellular Physiology and Biochemistry, 2018 - karger.com
A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …

Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA …

P Huang, L Wang, Q Li, X Tian, J Xu, J Xu… - Cardiovascular …, 2020 - academic.oup.com
Aims Naturally secreted nanovesicles, known as exosomes, play important roles in stem cell-
mediated cardioprotection. We have previously demonstrated that atorvastatin (ATV) …

[HTML][HTML] Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial …

LP Zhu, T Tian, JY Wang, JN He, T Chen, M Pan… - Theranostics, 2018 - ncbi.nlm.nih.gov
Exosomes (Exo) secreted from hypoxia-conditioned bone marrow mesenchymal stem cells
(BM-MSCs) were found to be protective for ischemic disease. However, the role of exosomal …

Induced pluripotent stem cell (iPSC)–derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs

M Adamiak, G Cheng, S Bobis-Wozowicz… - Circulation …, 2018 - Am Heart Assoc
Rationale: Extracellular vesicles (EVs) are tiny membrane-enclosed droplets released by
cells through membrane budding or exocytosis. The myocardial reparative abilities of EVs …

Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease

RG Gourdie, S Dimmeler, P Kohl - Nature reviews Drug discovery, 2016 - nature.com
Our understanding of the functions of cardiac fibroblasts has moved beyond their roles in
heart structure and extracellular matrix generation and now includes their contributions to …

VEGF-A in cardiomyocytes and heart diseases

M Braile, S Marcella, L Cristinziano… - International Journal of …, 2020 - mdpi.com
The vascular endothelial growth factor (VEGF), a homodimeric vasoactive glycoprotein, is
the key mediator of angiogenesis. Angiogenesis, the formation of new blood vessels, is …

Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in …

R Madonna, LW Van Laake, SM Davidson… - European heart …, 2016 - academic.oup.com
Despite improvements in modern cardiovascular therapy, the morbidity and mortality of
ischaemic heart disease (IHD) and heart failure (HF) remain significant in Europe and …

Stem cell therapy for chronic ischaemic heart disease and congestive heart failure

SA Fisher, C Doree, A Mathur… - Cochrane Database …, 2016 - cochranelibrary.com
Background A promising approach to the treatment of chronic ischaemic heart disease and
congestive heart failure is the use of stem cells. The last decade has seen a plethora of …

[HTML][HTML] Cardiomyocyte—endothelial cell interactions in cardiac remodeling and regeneration

V Talman, R Kivelä - Frontiers in cardiovascular medicine, 2018 - frontiersin.org
The heart is a complex organ consisting of various cell types, each of which plays an
important role in both physiological and pathophysiological conditions. The cells …